Publication of the final data from the clinical trial for mAbxience bevacizumab in metastatic colorectal cancer published in The Lancet Gastroenterology & HepatologyMiguel Martínez-Cava2018-09-27T12:05:35+02:00September 27, 2018|News|
Insud Pharma secures “very good” rating in the Profarma ProgrammeMiguel Martínez-Cava2018-09-24T13:32:46+02:00September 24, 2018|News|
The Autonomous University of Madrid and Insud Pharma join forces for biomedical innovationMiguel Martínez-Cava2018-09-24T17:54:32+02:00July 16, 2018|News|